Home688192 • SHA
add
Dizal Pharmaceutical Co Ltd
Previous close
¥57.69
Day range
¥56.39 - ¥58.64
Year range
¥32.72 - ¥59.71
Market cap
26.60B CNY
Avg Volume
4.29M
P/E ratio
-
Dividend yield
-
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 159.64M | 96.32% |
Operating expense | 341.52M | 12.54% |
Net income | -192.51M | 14.15% |
Net profit margin | -120.59 | 56.27% |
Earnings per share | — | — |
EBITDA | -178.52M | 16.76% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 898.76M | 10.02% |
Total assets | 1.80B | 16.27% |
Total liabilities | 1.78B | 108.18% |
Total equity | 23.53M | — |
Shares outstanding | 418.51M | — |
Price to book | 1.44K | — |
Return on assets | -26.81% | — |
Return on capital | — | — |
Cash Flow
Net change in cash
(CNY) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -192.51M | 14.15% |
Cash from operations | -131.67M | -4.44% |
Cash from investing | -128.65M | -112.84% |
Cash from financing | 262.62M | 26.52% |
Net change in cash | 2.34M | -88.91% |
Free cash flow | -166.67M | -34.96% |
About
Founded
Oct 27, 2017
Website
Employees
852